News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
53,320 Results
Type
Article (2293)
Company Profile (1)
Press Release (51025)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (16943)
Career Advice (180)
Deals (2666)
Drug Delivery (4)
Drug Development (6856)
Employer Resources (11)
FDA (913)
Job Trends (1285)
News (27123)
Policy (2130)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (333)
Accelerated approval (2)
Allergies (10)
Alliances (3213)
ALS (14)
Alzheimer's disease (146)
Antibody-drug conjugate (ADC) (21)
Approvals (949)
Artificial intelligence (30)
Autoimmune disease (15)
Automation (3)
Bankruptcy (24)
Best Places to Work (1147)
Biosimilars (7)
Biotechnology (5)
Bladder cancer (7)
Brain cancer (3)
Breast cancer (34)
Cancer (404)
Cardiovascular disease (28)
Career advice (154)
CAR-T (19)
CDC (1)
Cell therapy (55)
Cervical cancer (1)
Clinical research (5947)
Collaboration (103)
Compensation (46)
Complete response letters (2)
COVID-19 (290)
CRISPR (3)
C-suite (105)
Cystic fibrosis (8)
Data (673)
Decentralized trials (1)
Depression (3)
Diabetes (42)
Diagnostics (482)
Digital health (2)
Diversity, equity & inclusion (4)
Drug discovery (13)
Drug pricing (4)
Duchenne muscular dystrophy (13)
Earnings (5636)
Editorial (3)
Employer branding (3)
Employer resources (10)
Events (6030)
Executive appointments (155)
FDA (1158)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (6)
Funding (83)
Gene editing (11)
Generative AI (1)
Gene therapy (49)
GLP-1 (82)
Government (279)
Guidances (40)
Healthcare (1625)
HIV (4)
Huntington's disease (8)
IgA nephropathy (9)
Immunology and inflammation (22)
Immuno-oncology (2)
Indications (5)
Infectious disease (306)
Inflammatory bowel disease (16)
Influenza (6)
Intellectual property (25)
Interviews (32)
IPO (1348)
Job creations (170)
Job search strategy (138)
JPM (2)
Layoffs (19)
Leadership (2)
Legal (537)
Liver cancer (6)
Lung cancer (49)
Lymphoma (46)
Machine learning (1)
Management (2)
Manufacturing (38)
MASH (17)
Medical device (1141)
Medtech (1145)
Mergers & acquisitions (1389)
Metabolic disorders (107)
Multiple sclerosis (27)
Neurodegenerative disease (26)
Neuropsychiatric disorders (7)
Neuroscience (258)
NextGen: Class of 2026 (559)
Non-profit (319)
Now hiring (2)
Obesity (47)
Opinion (20)
Ovarian cancer (10)
Pain (19)
Pancreatic cancer (13)
Parkinson's disease (32)
Partnered (5)
Patents (52)
Patient recruitment (36)
People (8215)
Phase 1 (1720)
Phase 2 (2843)
Phase 3 (2031)
Pipeline (477)
Policy (7)
Postmarket research (143)
Preclinical (831)
Press Release (22)
Prostate cancer (31)
Psychedelics (3)
Radiopharmaceuticals (19)
Rare diseases (67)
Real estate (324)
Recruiting (3)
Regulatory (1638)
Reports (6)
Research institute (364)
Resumes & cover letters (23)
RSV (6)
Schizophrenia (7)
Series A (16)
Series B (12)
Service/supplier (1)
Sickle cell disease (11)
Special edition (2)
Spinal muscular atrophy (16)
Sponsored (1)
Startups (240)
Supply chain (3)
Tariffs (3)
The Weekly (1)
Vaccines (57)
Venture capital (3)
Weight loss (14)
Women's health (4)
Date
Last 7 days (34)
Last 30 days (123)
Last 365 days (2548)
2026 (190)
2025 (2628)
2024 (3271)
2023 (3676)
2022 (6150)
2021 (5758)
2020 (5191)
2019 (3787)
2018 (2856)
2017 (2420)
2016 (2087)
2015 (2509)
2014 (1671)
2013 (1235)
2012 (1242)
2011 (1405)
2010 (1370)
Location
Africa (54)
Alabama (4)
Alaska (1)
Arizona (19)
Asia (2242)
Australia (396)
California (787)
Canada (349)
China (53)
Colorado (50)
Connecticut (29)
Delaware (19)
Europe (6806)
Florida (176)
Georgia (6)
Idaho (5)
Illinois (58)
Indiana (59)
Iowa (8)
Japan (18)
Kansas (5)
Kentucky (1)
Louisiana (1)
Maine (16)
Maryland (178)
Massachusetts (609)
Michigan (11)
Minnesota (46)
Mississippi (1)
Missouri (12)
Nevada (2)
New Hampshire (5)
New Jersey (322)
New Mexico (1)
New York (413)
North Carolina (62)
Northern California (366)
Ohio (65)
Oklahoma (3)
Oregon (3)
Pennsylvania (249)
Puerto Rico (1)
Rhode Island (1)
South America (62)
South Carolina (2)
Southern California (368)
Tennessee (6)
Texas (199)
United States (3497)
Utah (19)
Vermont (1)
Virginia (51)
Washington D.C. (6)
Washington State (94)
West Virginia (1)
Wisconsin (4)
Wyoming (2)
53,320 Results for "numerate".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evaxion to present at numerous upcoming conferences
March 4, 2025
·
3 min read
Gene editing
Verve’s Base Editor ‘Numerically Beats’ Other Cholesterol-Lowering Drugs
In a Phase Ib trial, VERVE-102 showed it could lower bad cholesterol across doses, setting up an opt-in decision for Eli Lilly and a showdown with Novartis.
April 14, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Numerous Independent Groups Presented Data that Supports Apabetalone’s Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024
Numerous GLP-1 RA and SGLT2i presentations touted their clinical results, providing continued excitement for our BETonMACE program, which observed a non-prespecified 63% reduction in MACE and heart failure hazard among patients taking next-generation glucose lowering drugs
September 3, 2024
·
6 min read
FDA
Consistency in the Chaos: FDA Approvals Within Average Range as Q4 Kicks Off
Heading into the final quarter of a year that has seen dramatic upheaval at the FDA—from the exodus of numerous senior leaders to unclear policy changes and a safety saga that engulfed the gene therapy space—drug approvals appear roughly on par with recent years.
October 13, 2025
·
4 min read
·
Heather McKenzie
Press Releases
Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction
January 15, 2025
·
18 min read
Press Releases
Influenza Vaccine Market Size to Reach USD 12.5 Billion by 2032, Impelled by Numerous Favorable Initiatives by Government Bodies
July 29, 2024
·
10 min read
FDA
FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews
The program will bring together experts from across the FDA for a team-based review, rather than having an application move across numerous offices within the agency before getting a yay or nay.
June 17, 2025
·
2 min read
·
Annalee Armstrong
Biotech Beach
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Glaukos Corporation announced today that it will present multiple scientific abstracts at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held April 5-8, 2024 in Boston, MA.
April 1, 2024
·
9 min read
Press Releases
Theralase Discovers New Mechanism of Action of Lead Drug
Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar’s(TM) Ability to Inhibit DeUbiquitinating Enzymes, an Important Class of Enzymes Which Have Been Linked to Numerous Cancers and Neurogenerative Diseases
April 28, 2025
·
7 min read
Biotech Beach
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
Glaukos Corporation (NYSE: GKOS) announced today that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, being held November 3-6, 2023 in San Francisco, CA.
October 31, 2023
·
6 min read
1 of 5,332
Next
